Case Study
No Data or Staff Were Harmed During This Large-Scale Metabolomics Study
Dr. Romanas Chaleckis, PhD Assistant Professor Metabolomic Epidemiology Laboratory Gunma Initiative for Advanced Research (GIAR) Maebashi, Japan No Data or Staff Were Harmed During This Large-Scale Metabolomics Study Agilent case study: Metabolomics “We have this running joke about metabolomics: Every paper says phenylalanine or tryptophan is dysregulated! So if you see changes in tryptophan, at least you know you did metabolomics.” – Dr. Craig Wheelock The underlying concept of metabolomics-based healthcare is deceptively simple: the story of an individual's pathophysiology is written in their metabolites. Put another way, to know a person's metabolome is to know their health. But the real world is rarely simple. There are tens-to-hundreds of thousands of compounds in the human